Biomedical Engineering Reference
In-Depth Information
dihydropyrimidine dehydrogenase activity.
J. Clin. Oncol.
, 13: 1663-
1670.
13. Etienne, M.C., Lagrange, J.L., Dassonville, O., Fleming, R., Thyss, A.,
Renee, N., Schneider, M., Demard, F., and Milano, G. (1994): Population
study of dihydropyrimidine dehydrogenase in cancer patients.
J. Clin.
, 12: 2248-2253.
14. Ezzeldin, H., Johnson, M.R., Okamoto, Y., and Diasio, R. (2003):
Denaturing high performance liquid chromatography analysis of the
DPYD gene in patients with lethal 5-fluorouracil toxicity.
Oncol.
Clin. Cancer
, 9: 3021-3028.
15. Ezzeldin, H.H., Lee, A.M., Mattison, L.K., and Diasio, R.B. (2005):
Methylation of the DPYD promoter: an alternative mechanism for
dihydropyrimidine dehydrogenase deficiency in cancer patients.
Res.
Clin.
, 11: 8699-8705.
16. Fischer, J., Schwab, M., Eichelbaum, M., and Zanger, U.M. (2003):
Mutational analysis of the human dihydropyrimidine dehydrogenase
gene by denaturing high-performance liquid chromatography.
Cancer Res.
Genet.
, 7: 97-105.
17. Gamelin, E., Boisdron-Celle, M., Delva, R., Regimbeau, C., Cailleux, P.E.,
Alleaume, C., Maillet, M.L., Goudier, M.J., Sire, M., Person-Joly, M.C.,
Maigre, M., Maillart, P., Fety, R., Burtin, P., Lortholary, A., Dumesnil, Y.,
Picon, L., Geslin, J., Gesta, P., Danquechin-Dorval, E., Larra, F., and Robert,
J. (1998): Long-term weekly treatment of colorectal metastatic cancer
with fluorouracil and leucovorin: results of a multicentric prospective
trial of fluorouracil dosage optimization by pharmacokinetic
monitoring in 152 patients.
Test.
, 16: 1470-1478.
18. Gamelin, E., Delva, R., Jacob, J., Merrouche, Y., Raoul, J.L., Pezet, D.,
Dorval, E., Piot, G., Morel, A., and Boisdron-Celle, M. (2008): Individual
fluorouracil dose adjustment based on pharmacokinetic follow-
up compared with conventional dosage: results of a multicenter
randomized trial of patients with metastatic colorectal cancer.
J. Clin. Oncol.
J. Clin.
, 26: 2099-2105.
19. Gross, E., Busse, B., Riemenschneider, M., Neubauer, S., Seck, K., Klein,
H.G., Kiechle, M., Lordick, F., and Meindl, A. (2008): Strong association
of a common dihydropyrimidine dehydrogenase gene polymorphism
with fluoropyrimidine-related toxicity in cancer patients.
Oncol.
PLoS. One.
,
3: e4003.
20. Gross, E., Ullrich, T., Seck, K., Mueller, V., de, W.M., von, S.C., Meindl, A.,
Schmitt, M., and Kiechle, M. (2003): Detailed analysis of five mutations
